Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HBV elimination in Africa-Current status and challenges.
Sonderup MW, Spearman CW. Sonderup MW, et al. Clin Liver Dis (Hoboken). 2024 May 3;23(1):e0166. doi: 10.1097/CLD.0000000000000166. eCollection 2024 Jan-Jun. Clin Liver Dis (Hoboken). 2024. PMID: 38707243 Free PMC article. Review.
Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study.
Minier N, Guingané AN, Okeke E, Sinkala E, Johannessen A, Andersson MI, Davwar P, Desalegn H, Duguru M, Fall F, Mboup S, Maponga T, Matthews PC, Ramírez Mena A, Ndow G, Orlien SMS, Riches N, Seydi M, Sonderup M, Spearman CW, Stockdale AJ, Taljaard J, Vinikoor M, Wandeler G, Lemoine M, Shimakawa Y, Sombié R. Minier N, et al. Among authors: sonderup m. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):323-332. doi: 10.1016/S2468-1253(23)00449-1. Epub 2024 Feb 15. Lancet Gastroenterol Hepatol. 2024. PMID: 38367633 Free PMC article.
Managing cirrhosis with limited resources: perspectives from sub-Saharan Africa.
Sonderup MW, Kamath PS, Awuku YA, Desalegn H, Gogela N, Katsidzira L, Tzeuton C, Bobat B, Kassianides C, Spearman CW; Gastroenterology and Hepatology Association of sub-Saharan Africa. Sonderup MW, et al. Lancet Gastroenterol Hepatol. 2024 Feb;9(2):170-184. doi: 10.1016/S2468-1253(23)00279-0. Lancet Gastroenterol Hepatol. 2024. PMID: 38215781 Review.
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, Invernizzi P, Jones D, Kruger FC, Lawitz E, Mayo MJ, Shiffman ML, Swain MG, Valera JM, Vargas V, Vierling JM, Villamil A, Addy C, Dietrich J, Germain JM, Mazain S, Rafailovic D, Taddé B, Miller B, Shu J, Zein CO, Schattenberg JM; ELATIVE Study Investigators’ Group; ELATIVE Study Investigators' Group. Kowdley KV, et al. N Engl J Med. 2024 Feb 29;390(9):795-805. doi: 10.1056/NEJMoa2306185. Epub 2023 Nov 13. N Engl J Med. 2024. PMID: 37962077 Clinical Trial.
Joint statement in support of hepatitis C human challenge studies.
Alter HJ, Barnes E, Biondi MJ, Cox AL, Eberts JD, Feld JJ, Liang TJ, Morrison J, Rice CM, Shoukry NH, Thomas DL, Van Gennip J, Weijer C; other signatories. Alter HJ, et al. Lancet Gastroenterol Hepatol. 2023 Nov;8(11):967-969. doi: 10.1016/S2468-1253(23)00314-X. Epub 2023 Sep 21. Lancet Gastroenterol Hepatol. 2023. PMID: 37742699 No abstract available.
Ivermectin drug induced liver injury.
Sonderup M, Mudini W, Spearman W. Sonderup M, et al. S Afr Med J. 2023 Jun 5;113(6):24-25. doi: 10.7196/SAMJ.2023.v113i6.624. S Afr Med J. 2023. PMID: 37278267 Free article.
88 results